Loïc Lemiègre

Dr. Loïc Lemiègre

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Journal of Controlled Release
Verified
Journal Article
Closed access
AMA. Le Moignic
A. Le Moignic
VMV. Malard
V. Malard
TBT. Benvegnu
T. Benvegnu
LLLoïc Lemiègre
Loïc Lemiègre
MBM. Berchel
M. Berchel
VMV. Mateo
V. Mateo

1 June 2009 in Biochimie
Verified
Journal Article
Closed access
AJAlicia Jacquemet
Alicia Jacquemet
JBJulie Barbeau
Julie Barbeau
LLLoïc Lemiègre
Loïc Lemiègre
TBThierry Benvegnu
Thierry Benvegnu

13 May 2005 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
HIHiroyuki Isobe
Hiroyuki Isobe
TTTakatsugu Tanaka
Takatsugu Tanaka
WNWaka Nakanishi
Waka Nakanishi
LLLoïc Lemiègre
Loïc Lemiègre
ENEiichi Nakamura
Eiichi Nakamura

1 November 2009 in Recent Advances in Drug Delivery and Formulation
Verified
Journal Article
Closed access
PDF file
TBThierry Benvegnu
Thierry Benvegnu
LLLoïc Lemiègre
Loïc Lemiègre
Sandrine Cammas-MarionSandrine Cammas-Marion
Sandrine Cammas-Marion
Archaeosomes made from natural archaeal membrane lipids and/or synthetic lipid analogues have been extensively studied for potential applications in drug and vaccine delivery over the past decade only. Archaeal-type lipids consist of archaeol (diether) and/or caldarchaeol (tetraether) core structures wherein regularly branched and usually fully saturated phytanyl chains (20-40 carbons in lengths), are attached via ether bonds to the sn-2,3 carbons of the glycerol backbone. Archaeosomes constitute a novel generation of liposomes that exhibit high stabilities to low or high temperatures, acidic or alkaline pH, oxidative conditions, high pressure, action of phospholipases, bile salts and serum proteins. These properties associated with a good safety profile are beneficial for nanotechnological applications in drug and gene delivery. Additionally, archaeosome formulations could be used as efficient carriers of antigens and/or adjuvants promoting antigen-specific, humoral and cell-mediated immune responses, in addition to antigen-specific mucosal immune responses in the vaccinated hosts. The immune responses are well sustained over time, and are subject to strong memory responses. Nanodelivery-based vaccinations using archaeosomes could then represent a promising approach for treating and preventing infections, allergies, and neoplastic or cancer diseases. In this review, the few recent US, World and European patents developing archaeosomes for these biotechnological applications in Health are discussed.

10 October 2008 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JCJonathan D. Clayden
Jonathan D. Clayden
LLLoïc Lemiègre
Loïc Lemiègre
GMGareth A. Morris
Gareth A. Morris
MPMark Pickworth
Mark Pickworth
TSTimothy J. Snape
Timothy J. Snape
LJLyn H. Jones
Lyn H. Jones

10 January 2008 in Green Chemistry
Verified
Journal Article
Closed access
PDF file
FGFabrice Goursaud
Fabrice Goursaud
MBMathieu Berchel
Mathieu Berchel
JGJérôme Guilbot
Jérôme Guilbot
NLNathalie Legros
Nathalie Legros
LLLoïc Lemiègre
Loïc Lemiègre
TBThierry Benvegnu
Thierry Benvegnu
This article describes the synthesis, properties and potential applications of new cationic surfactants based on natural glycine betaine and vegetable oils as renewable raw materials. Convenient procedures were developed on a multigram scale using environmentally friendly starting materials to provide glycine betaine-derived esters and amides. Some readily biodegradable formulations containing ester-type surfactant were found to exhibit remarkable emulsifying properties for road making applications and they are now under industrial development using green solvent-free processes. Bipolar bolaamphiphiles possessing two cationic glycine betaine moieties were synthesized as monomers for the preparation of original drug delivery liposomal systems.